Cd(II) complexes form monomers/dimers depending on bispyrazolyl ligand
NC6H3(CH3)2―), 113.75 (2C, o-NC6H3(CH3)2―), 106.17 (2C,
―N―CH CH―CH N―), 66.32 (2C, ―CH2―), 21.65 (2C, ―NC6H3
(CH3)2―). IR (solid neat; cmÀ1): 3124 (w), 2915 (w), 1595 (s), 1475
(w), 1387 (s), 1323 (w), 1278 (w), 1160 (s), 1082 (w), 1038 (s), 955
(s), 882 (s), 827 (w),744 (s), 612 (s).
105.94 (2C, ―N CH―CH CH―N―), 66.22 (s, 2C, ―CH2―). IR (solid
neat; cmÀ1): 3838 (w), 3739 (w), 3616 (w), 1751 (s), 1700 (s), 1591
(w), 1502 (w), 1409 (s), 1363 (s), 1328 (w), 1255 (w), 1187 (w), 1155
(s), 1099 (s), 1058 (s), 981 (s), 940 (w), 757 (s), 646 (s), 609 (s).
[N,N-Bis(1H-pyrazolyl-1-methyl)-p-methylaniline(μ-bromo)Cd(II) bromide]2
([L2CdBr2]2)
N,N-Bis(3,5-dimethyl-1H-pyrazolyl-1-methyl)aniline (L4)
[L2CdBr2]2 was prepared according to a similar procedure as de-
scribed for [L1CdBr2]2. The white powder was filtered and
washed with ethanol (50.0 ml × 2), followed by washing with
diethyl ether (50.0 ml × 2) (0.41 g, 38.0%). Analysis. Calcd for
C30H34Br4Cd2N10: C, 33.39; H, 3.18; N, 12.98%. Found: C, 33.17;
L4 was prepared by an analogous method as described for L1
except that 3,5-dimethyl-1H-pyrazolyl-1-methanol was utilized.
The white solid product was obtained (4.20 g, 67.9%). Analysis.
Calcd for C18H23N5: C, 69.87; H, 7.49; N, 22.63%. Found: C, 69.86;
H, 7.51; N, 22.64%. 1H NMR (CDCl3, 400 MHz): δ 7.20 (dd, 2H,
J = 7.8 Hz, J = 7.2 Hz, m-NC6H5―), 7.12 (d, 2H, J = 7.8 Hz, o-
NC6H5―), 6.82 (t, 1H, J = 7.2 Hz, p-NC6H5―), 5.78 (s, 2H, ―N―C
(CH3) CH―C(CH3) N―), 5.64 (s, 4H, ―CH2―), 2.16 (s, 6H,
―N―C(CH3) CH―C(CH3) N―), 2.08 (s, 6H, ―N―C(CH3)
CH―C(CH3) N―). 13C NMR (CDCl3, 100 MHz): δ 146.58 (1C,
ipso-NC6H5―), 146.13 (2C, m-NC6H5―) 139.43 (2C, ―N―C(CH3)
CH―C(CH3) N―), 129.19 (2C, ―N―C(CH3) CH―C(CH3) N―),
120.50(1C, p-NC6H5―), 117.28 (s, 2C, o-NC6H5―), 105.76 (2C,
―N―C(CH3) CH―C(CH3) N―), 63.67 (2C, ―CH2―), 13.63 (2C,
―N―C(CH3) CH―C(CH3) N―), 11.07 (2C, ―N―C(CH3) CH―C
(CH3) N―). IR (solid neat; cmÀ1): 3289 (w), 2921 (w), 1598 (s),
1549 (s), 1506 (s), 1454 (s), 1387 (w), 1254 (s), 1211 (w), 1153
(w), 1028 (s), 953 (s), 816 (s), 748 (w), 683 (s), 623 (s).
1
H, 3.16; N, 13.07%. H NMR (DMSO-d6, 400 MHz): δ 7.82 (d, 2H,
J = 2.2 Hz, ―N CH―CH CH―N―), 7.50 (d, 2H, J = 1.2 Hz,
―N CH―CH CH―N―), 7.04 (d, 2H, J = 8.8 Hz, o-NC6H4CH3―),
6.98 (d, 2H, J = 8.6 Hz, m-NC6H4CH3―), 6.25 (dd, 2H, J = 2.2 Hz,
J = 1.2 Hz, ―N CH―CH CH―N―), 5.88 (s, 4H, ―CH2―), 2.16 (s,
3H, ―NC6H4CH3―). 13C NMR (DMSO-d6, 100 MHz): δ 143.18 (1C,
ipso-NC6H4CH3―), 139.38 (2C, ―N CH―CH CH―N―), 129.94
(2C, ―N CH―CH CH―N―), 129.79(1C, p-NC6H4CH3―), 128.41
(2C, m-NC6H4CH3―), 114.61 (2C, o-NC6H4CH3―), 105.88 (2C,
―N CH―CH CH―N―), 66.41 (2C, ―CH2―), 20.27 (1C,
―NC6H4CH3―). IR (solid neat; cmÀ1): 3847 (w), 3742 (w), 3619
(w), 1753 (s), 1695 (s), 1647 (s), 1516 (s), 1405 (w), 1318 (w),
1253 (w), 1169 (s), 1098 (s), 1055 (s), 948 (w), 774 (s), 610 (s).
N,N-Bis(1H-pyrazolyl-1-methyl)-2,6-dimethylaniline (L5)
[N,N-Bis(1H-pyrazolyl-1-methyl)-3,5-dimethylaniline(μ-bromo)Cd(II) bromide]
([L3CdBr2]2)
2
L5 was prepared by an analogous method as described for L1 ex-
cept that 2,6-dimethyl-1H-pyrazolyl-1-methanol was utilized. A
white solid product was obtained (4.35 g, 77.3%). Analysis. Calcd
for C16H19N5: C, 68.30; H, 6.81; N, 24.89%. Found: C, 68.12; H, 6.82; N,
25.05%. 1H NMR (CDCl3, 400MHz): δ 7.54 (d, 2H, J=2.0Hz,
―NCH―CH CH―N―), 7.28 (d, 2H, J=2.0Hz, ―NCH―CH CH―N―),
7.00 (m, 3H, m,o-NC6H3(CH3)2―), 6.22 (dd, 2H, J=2.0Hz, J=J=2.0Hz,
―NCH―CHCH―N―), 5.36 (s, 4H, ―CH2―), 1.78 (s, 6H, ―NC6H3
(CH3)2―). 13C NMR (CDCl3, 100 MHz): δ 143.48 (1C, ipso-NC6H3
[L3CdBr2]2 was prepared according to a similar procedure de-
scribed for [L1CdBr2]2. The white powder was filtered and
washed with ethanol (50.0 ml × 2), followed by washing with
diethyl ether (50.0 ml × 2) (0.45 g, 40.6%). Analysis. Calcd for
C32H38Br4Cd2N10: C, 34.71; H, 3.46; N, 12.65%. Found: C, 35.56;
1
H, 3.48; N, 12.92%. H NMR (DMSO-d6, 400 MHz): δ 7.83 (d, 2H,
J = 2.0 Hz, ―N CH―CH CH―N―), 7.51 (d, 2H, J = 2.0 Hz,
―N CH―CH CH―N―), 6.78 (s, 2H, o-NC6H3(CH3)2―), 6.44 (s,
1H, p-NC6H3(CH3)2―), 6.26 (dd, 2H, J = 2.0 Hz, J = 2.0 Hz,
―N CH―CH CH―N―), 5.88 (s, 4H, ―CH2―), 2.20 (s, 6H,
―NC6H3(CH3)2―). 13C NMR (DMSO-d6, 100 MHz): δ 145.53 (1C,
ipso-NC6H3(CH3)2―), 139.39 (2C, ―N CH―CH CH―N―), 138.30
(2C, m-NC6H3(CH3)2―), 129.93 (2C, ―N CH―CH CH―N―),
121.45 (1C, p-NC6H3(CH3)2―), 112.39 (2C, o-NC6H3(CH3)2―),
105.88 (2C, ―N CH―CH CH―N―), 66.17 (2C, ―CH2―), 21.71
(2C, ―NC6H3(CH3)2―). IR (solid neat; cmÀ1): 3871 (w), 3741 (w),
3619 (w), 1697 (s), 1595 (s), 1514 (s), 1463 (s), 1409 (s), 1335 (s),
1246 (w), 1172 (w), 1063 (s), 965 (w), 885 (s), 833 (s), 750 (s), 695
(s), 609 (s).
(CH3)2―),
139.91 (2C,
―N CH―CH CH―N―)
137.16
(2C, ―N CH―CH CH―N―), 129.29 (2C, m-NC6H3(CH3)2―),
128.88 (2C, o-NC6H3(CH3)2―), 126.78 (1C, p-NC6H3(CH3)2―),
106.02 (2C, ―N CH―CH CH―N―), 67.96 (2C, ―CH2―), 17.79
(2C, ―NC6H3(CH3)2―). IR (solid neat; cmÀ1): 3317 (w), 2947 (w),
1836 (s), 1745 (w), 1699 (s), 1550 (w), 1266 (s), 1106 (s), 1070 (s),
1030 (s), 980 (w), 943 (w), 771 (w), 630 (s), 582 (s).
[N,N-Bis(1H-pyrazolyl-1-methyl)aniline(μ-bromo)Cd(II) bromide]2 ([L1CdBr2]2)
A solution of L1 (0.253 g, 25.3 mg, 1.00 mmol) in dried ethanol
(10.0 ml) was added to a solution of CdBr2.4H2O (0.334 g,
33.4 mg, 1.00 mmol) in dried ethanol (10.0 ml) at room tempera-
ture. Precipitation of white material occurred while stirring at
room temperature for 12 h. The white powder was filtered and
washed with ethanol (50.0 ml × 2), followed by washing with
diethyl ether (50.0 ml × 2) (0.41 g, 78.0%). Analysis. Calcd for
C28H30Br4Cd2N10: C, 32.00; H, 2.88; N, 13.33%. Found: C, 32.02;
N,N-Bis(3,5-dimethyl-1H-pyrazolyl-1-methyl)anilineCd(II) bromide ([L4CdBr2])
[L4CdBr2] was prepared according to a similar procedure de-
scribed for [L1CdBr2]2. The white powder was filtered and
washed with ethanol (50.0 ml × 2), followed by washing with
diethyl ether (50.0 ml × 2) (0.43 g, 73.9%). Analysis. Calcd for
C18H23Br2CdN5: C, 37.17; H, 3.99; N, 12.04%. Found: C, 37.28; H,
4.04; N, 12.18%. 1H NMR (DMSO-d6, 400 MHz): δ 7.19 (dd, 2H,
J = 7.8 Hz, J = 7.2 Hz, m-NC6H5―), 7.11 (d, 2H, J = 7.8 Hz, o-
NC6H5―), 6.82 (t, 1H, J = 7.2 Hz, p-NC6H5―), 5.79 (s, 2H, ―N―C
(CH3) CH―C(CH3) N―), 5.63 (s, 4H, ―CH2―), 2.15 (s, 6H,
―N―C(CH3) CH―C(CH3) N―), 2.09 (s, 6H, ―N―C(CH3)
CH―C(CH3) N―). 13C NMR (DMSO-d6, 100 MHz): δ 146.58 (1C,
ipso-NC6H5―), 146.10 (2C, o-NC6H5―) 139.48 (2C, ―N―C(CH3)
CH―C(CH3) N―), 129.26 (2C, ―N―C(CH3) CH―C(CH3) N―),
1
H, 2.87; N, 13.71%. H NMR (DMSO-d6, 400 MHz): δ 7.84 (d, 2H,
J=2.4Hz, ―N CH―CH CH―N―), 7.51 (d, 2H, J=1.2Hz,
―N CH―CH CH―N―), 7.20 (d, 2H, J=9.0Hz, o-NC6H5―), 7.17
(dd, 2H, J=9.0Hz, J=6.6Hz, m-NC6H5―), 6.79 (t, 1H, J=6.6Hz,
p-NC6H5―),
―N CH―CH CH―N―), 5.92 (s, 4H, ―CH2―). 13C NMR (DMSO-d6,
100 MHz): 145.55 (1C, ipso-NC6H5―), 139.44 (2C,
6.26
(dd,
2H,
J=2.4Hz,
J=1.2Hz,
δ
―N CH―CH CH―N―), 130.00 (2C, ―N CH―CH CH―N―), 129.37
(2C, m-NC6H5―), 119.65 (1C, p-NC6H5―), 114.36 (2C, o-NC6H5―),
Appl. Organometal. Chem. 2014, 28, 445–453
Copyright © 2014 John Wiley & Sons, Ltd.
wileyonlinelibrary.com/journal/aoc